Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HIV
HIV
Merck Announces Data from Ph III Study of Investigational HIV Therapy Doravirine
CP Wire
Tue, 07/24/18 - 10:11 am
Merck
Doravirine
HIV
Gilead Announces Data on Truvada for HIV Prophylaxis
CP Wire
Tue, 07/24/18 - 12:47 pm
Gilead Sciences
Truvada
HIV
Merck Announces Data from Ph III Study of Investigational HIV Therapy Doravirine
Tue, 07/24/18 - 09:55 am
Merck
Doravirine
HIV
Gilead Announces Data on Truvada for HIV Prophylaxis
Tue, 07/24/18 - 12:47 pm
Gilead Sciences
HIV
Truvada
Where does J&J's new drug fit in the crowded HIV market?
Biopharma Dive
Wed, 07/18/18 - 09:54 pm
JNJ
Janssen
FDA
HIV
Symtuza
4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit?
Motley Fool
Mon, 07/16/18 - 09:21 am
HIV
Gilead Sciences
Biktarvy
GSK
Triumeq
Genvoya
Tivicay
Positive momentum for French biotech industry continues: Abivax announces positive Phase II results (HIV)
GoinPharma
Mon, 07/9/18 - 10:56 am
France
Abivax
ABX464-005
HIV
Abivax up on mixed HIV data
Biopharma Dive
Wed, 07/4/18 - 10:02 am
ABX464
Abivax
HIV
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
Yahoo/Reuters
Wed, 06/20/18 - 09:28 am
GSK
Gilead Sciences
HIV
AIDS
Dolutegravir
lamivudine
Biktarvy
ViiV Healthcare reports positive results for late-stage HIV trials
Marketwatch
Thu, 06/14/18 - 09:19 am
ViiV Healthcare
GSK
Pfizer
Shionogi
HIV
clinical trials
Dolutegravir
lamivudine
New HIV vaccine test shows promise
Axios
Wed, 06/6/18 - 03:07 pm
HIV
vaccines
Gilead, Hookipa pen hepatitis B, HIV research collaboration
Fierce Biotech
Wed, 06/6/18 - 09:34 am
Gilead Sciences
Hookipa
hepatitis B
HIV
vaccines
drug development
ViiV Receives EU Authorization for Juluca, the First 2-Drug, Once-Daily Pill for HIV
CP Wire
Mon, 05/21/18 - 09:08 am
ViiV Healthcare
Juluca
Europe
HIV
ViiV Receives EU Authorization for Juluca, the First 2-Drug, Once-Daily Pill for HIV
Mon, 05/21/18 - 08:31 am
ViiV Healthcare
HIV
Juluca
Regulators flag possible birth defect link to GSK's HIV drug
Yahoo/Reuters
Fri, 05/18/18 - 09:27 pm
GSK
HIV
Dolutegravir
birth defects
EMA
FDA
HIV Patients File Class Action and Personal Injury Lawsuits for California Patients Against Gilead
CP Wire
Wed, 05/9/18 - 09:27 am
Gilead Sciences
HIV
patients
TDF
TAF
California
GlaxoSmithKline's next-generation HIV battle against Gilead is already taking a toll on growth
Fierce Pharma
Sat, 04/28/18 - 12:13 pm
GSK
HIV
Biktarvy
Gilead Sciences
Triumeq
Tivicay
Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy
CP Wire
Fri, 04/27/18 - 11:39 am
Gilead Sciences
Biktarvy
HIV
Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy
Fri, 04/27/18 - 09:56 am
Gilead Sciences
Biktarvy
HIV
Look at our new launches, GSK urges, as its respiratory woes steal the limelight
Fierce Pharma
Wed, 04/25/18 - 10:38 pm
GSK
earnings
HIV
Shingrix
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »